Aspirin

Platelet Mab rDNA

Platelet dysfunction

Platelet Factors

Suspected platelet dysfunction

'Resistance' to low-dose aspirin therapy extremely rare, according to new study

In a study of 400 healthy volunteers, researchers went looking for people who are truly resistant to the benefits of aspirin. They failed to find one case of aspirin resistance; rather, they found “...

'Resistance' to low-dose aspirin therapy extremely rare

(University of Pennsylvania School of Medicine) In a study of 400 healthy volunteers, researchers went looking for people who are truly resistant to the benefits of aspirin. They failed to find one ca...

Low-dose aspirin favored after PCI for STEMI

NEW YORK (Reuters Health) - Low-dose aspirin is better than high-dose aspirin after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), say researchers...

Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case–control study

Study questions value of coated, low-dose aspirin therapy

Roughly one-fifth of Americans take low-dose aspirin every day for heart-healthy benefits. But, based on either urine or blood tests of how aspirin blocks the stickiness of platelets - blood cells tha...

"Resistance" To Low-Dose Aspirin Therapy Extremely Rare, According To Penn Study

Roughly one-fifth of Americans take low-dose aspirin every day for heart-healthy benefits. But, based on either urine or blood tests of how aspirin blocks the stickiness of platelets - blood cells tha...

'Resistance' to low-dose aspirin therapy extremely rare, study finds

(Medical Xpress)—Roughly one-fifth of Americans take low-dose aspirin every day for heart-healthy benefits. But, based on either urine or blood tests of how aspirin blocks the stickiness of platel...

Low-dose prasugrel reduces high on-clopidogrel platelet reactivity in elderly

NEW YORK (Reuters Health) - In older patients with acute coronary syndrome (ACS) and high on-clopidogrel platelet reactivity, reduced-dose prasugrel (5 mg/d) was significantly more effective than...

Can resistance to aspirin be reversed after an additional dose?

Aspirin resistance or aspirin non-responsiveness is a recently described phenomenon which has been consistently associated with an increased risk of cardiovascular events. This study was designed to d...

ANTI-PLATELET THERAPY: CYCLOOXYGENASE INHIBITION AND THE USE OF ASPIRIN WITH PARTICULAR REGARD TO DUAL ANTI-PLATELET THERAPY.

Aspirin and P2Y(12) antagonists are commonly used anti-platelet agents. Aspirin produces its effects through inhibition of thromboxane A(2) (TXA(2) ) production while P2Y(12) antagonists attenuate the...

Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy.

To develop an integrated metric of non-COX-1-dependent platelet function (NCDPF) to measure the temporal response to aspirin in healthy volunteers and diabetics. NCDPF on aspirin demonstrates wide var...

Effects of various doses of aspirin on platelet activity and endothelial function.

Although aspirin has become an established medicine for cardiac and cerebrovascular diseases, the optimal dose remains unknown. We evaluated the optimal dose of aspirin on platelet activity and endoth...

Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.

Aspirin treatment reduces cardiovascular events and deaths in high-risk non-diabetic patients, but not in patients suffering from diabetes. In these patients, hyperglycemia has been found to cause red...